BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2568418)

  • 1. Effects of anti-inflammatory drugs on interleukin 1-induced cartilage proteoglycan resorption in-vitro: inhibition by aurothiophosphines but no influence from perturbed eicosanoid metabolism.
    Rainsford KD
    J Pharm Pharmacol; 1989 Feb; 41(2):112-7. PubMed ID: 2568418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti-inflammatory drugs and agents that modify intracellular transduction signals or metabolic activities in inflammatory cells on interleukin-1 induced cartilage proteoglycan resorption in vitro.
    Rainsford KD
    Pharmacol Res; 1992; 25(4):335-46. PubMed ID: 1329061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycan synthesis, and prostaglandin E2 release from cartilage in organ culture.
    Arner EC; Pratta MA
    Arthritis Rheum; 1989 Mar; 32(3):288-97. PubMed ID: 2784682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ebselen on IL-1-induced alterations in cartilage metabolism.
    Pratta MA; Ackerman NR; Arner EC
    Inflamm Res; 1998 Mar; 47(3):115-21. PubMed ID: 9562336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin is a potent inhibitor of interleukin 1 induced cartilage proteoglycan resorption in-vitro.
    Rainsford KD
    J Pharm Pharmacol; 1989 Jan; 41(1):60-3. PubMed ID: 2565969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antimalarial drugs on interleukin 1-induced cartilage proteoglycan degradation in-vitro.
    Rainsford KD
    J Pharm Pharmacol; 1986 Nov; 38(11):829-33. PubMed ID: 2879013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
    Rainsford KD; Ying C; Smith FC
    J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiinflammatory drugs on human interleukin-1-induced cartilage degradation.
    Arner EC; Darnell LR; Pratta MA; Newton RC; Ackerman NR; Galbraith W
    Agents Actions; 1987 Aug; 21(3-4):334-6. PubMed ID: 3500594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondrocytes and antirheumatic drugs.
    Raiss RX; Karbowski A; Aigner T; Schleyerbach R
    J Rheumatol Suppl; 1995 Feb; 43():152-4. PubMed ID: 7538587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by cysteine endopeptidase inactivators.
    Buttle DJ; Saklatvala J; Barrett AJ
    Agents Actions Suppl; 1993; 39():161-5. PubMed ID: 8456627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of azapropazone on cellular events at inflamed sites. Influence on joint pathology in arthritic rats, leucocyte superoxide and eicosanoid production, platelet aggregation, synthesis of cartilage proteoglycans, synovial production and actions of interleukin-1 in cartilage resorption correlated with drug uptake into cartilage in-vitro.
    Rainsford KD; Davies A; Mundy L; Ginsburg I
    J Pharm Pharmacol; 1989 May; 41(5):322-30. PubMed ID: 2569519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage.
    Saklatvala J
    Nature; 1986 Aug 7-13; 322(6079):547-9. PubMed ID: 3736671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiinflammatory drugs on the release from porcine synovial tissue in vitro of interleukin 1 like cartilage degrading activity.
    Rainsford KD
    Agents Actions; 1987 Aug; 21(3-4):337-40. PubMed ID: 3500595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1: purification and biochemical aspects of its action on cartilage.
    Saklatvala J
    J Rheumatol; 1987 May; 14 Spec No():52-4. PubMed ID: 3498042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage.
    Hardingham TE; Bayliss MT; Rayan V; Noble DP
    Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of NSAID and steroids on cartilage destruction in murine antigen induced arthritis.
    van den Berg WB
    J Rheumatol Suppl; 1991 Feb; 27():122-3. PubMed ID: 2027110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interleukin-1 on the size distribution of cartilage proteoglycans as determined by sedimentation field flow fractionation.
    Arner EC; Kirkland JJ
    Biochim Biophys Acta; 1989 Oct; 993(1):100-7. PubMed ID: 2804117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation.
    Buttle DJ; Saklatvala J
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):657-61. PubMed ID: 1445226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins in human cartilage metabolism.
    Dingle JT
    J Lipid Mediat; 1993; 6(1-3):303-12. PubMed ID: 8357988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.